Campbell & Co. Investment Adviser »

Arcutis Biotherapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $752k 40k 18.85
2025-06-30 $226k 16k 14.02
2025-03-31 $1.2M 75k 15.64
2024-12-31 $1.1M 76k 13.93
2024-09-30 $703k 76k 9.30

More positions owned by Campbell & Co. Investment Adviser

Wheaton Precious Metals Corp Common Stock (WPM)
Rio Tinto Adr (RIO)
Sprouts Farmers Market Common Stock (SFM)
PTC Common Stock (PTC)
Agnico Eagle Mines Common Stock (AEM)
OGE Energy Corp Common Stock (OGE)
Paychex Common Stock (PAYX)
CMS Energy Corp Common Stock (CMS)
Royal Gold Common Stock (RGLD)
Logitech International SA Common Stock (LOGI)
Franklin Resources Common Stock (BEN)
Meta Platforms Common Stock (META)
Graphic Packaging Holding Common Stock (GPK)
Kinder Morgan Common Stock (KMI)
Pan American Silver Corp Common Stock (PAAS)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Vanguard Group
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
Morgan Stanley
UBS Group
Geode Capital Management
Henderson Group
Franklin Resources
Pivotal bioVenture Partners Investment Advisor

View all funds holding Arcutis Biotherapeutics